KEY FEATURES
| Full Name | Fatty Acid Binding Protein 5, Epidermal |
|---|---|
| Synonym | E-FABP; EFABP; PA-FABP; PAFABP; Fatty Acid Binding Protein 5, Epidermal; Psoriasis-Associated; Epidermal-type fatty acid-binding protein; Psoriasis-associated fatty acid-binding protein homolog |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 0.31-20ng/mL |
| Sensitivity | 0.12ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human FABP5 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human FABP5. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human FABP5 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human FABP5, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human FABP5. You can calculate the concentration of Human FABP5 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human FABP5 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 0.93 | 2.15 | 7.47 | 0.99 | 1.94 | 8.02 |
| Standard deviation | 0.05 | 0.1 | 0.28 | 0.06 | 0.1 | 0.37 |
| CV(%) | 5.14 | 4.73 | 3.71 | 6.3 | 5.3 | 4.6 |
RECOVERY
The recovery of Human FABP5 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 83-95 | 90 |
| EDTA plasma (n=8) | 85-95 | 90 |
| Cell culture media (n=8) | 87-100 | 92 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human FABP5 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with FABP5 ELISA Kits
| S100A7 ELISA Kit | publications with FABP5 and S100A7 |
| FAAH ELISA Kit | publications with FABP5 and FAAH |
| S100A7A ELISA Kit | publications with FABP5 and S100A7A |
Pathways associated with FABP5 ELISA Kit
| PPAR Signaling Pathway | PPAR Signaling Pathway |
| Signal Transduction Pathway | Signal Transduction Pathway |
| Signaling By Retinoic Acid Pathway | Signaling By Retinoic Acid Pathway |
Diseases associated with FABP5 ELISA Kit
| Fatty Liver | publications with FABP5 and Fatty Liver |
| Inflammation | publications with FABP5 and Inflammation |
| Disease Models, Animal | publications with FABP5 and Disease Models, Animal |
| Liver Diseases | publications with FABP5 and Liver Diseases |
| Cardiovascular Diseases | publications with FABP5 and Cardiovascular Diseases |
| Nervous System Diseases | publications with FABP5 and Nervous System Diseases |
| Atherosclerosis | publications with FABP5 and Atherosclerosis |
| Necrosis | publications with FABP5 and Necrosis |
| Heart Diseases | publications with FABP5 and Heart Diseases |
| Neoplasms, Experimental | publications with FABP5 and Neoplasms, Experimental |
Organs/Tissues associated with FABP5 ELISA Kit
| Liver | publications with FABP5 and Liver |
| Adipose Tissue | publications with FABP5 and Adipose Tissue |
| Intestine | publications with FABP5 and Intestine |
| Heart | publications with FABP5 and Heart |
| Connective Tissue | publications with FABP5 and Connective Tissue |
| Blood | publications with FABP5 and Blood |
| Muscle | publications with FABP5 and Muscle |
| Skin | publications with FABP5 and Skin |
| Brain | publications with FABP5 and Brain |
| Embryonic Tissue | publications with FABP5 and Embryonic Tissue |